CIK 0001840439 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Biomea Fusion, Inc.
Sign in to watch- Ticker
- BMEA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (650) 980-9099
- Business address
- 1599 INDUSTRIAL ROAD, SAN CARLOS, CA, 94070
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-31 | A2A Pharmaceuticals, Inc. 10% owner | Sale | −200,000 | $31.25 | $6.3M | 4,100,000 |
| 2023-03-31 | A2A Pharmaceuticals, Inc. 10% owner | Sale | +200,000 | $31.25 | $6.3M | 4,100,000 |
| 2023-03-30 | Chen Bihua Director | Purchase | +400,000 | $30.00 | $12.0M | 3,570,872 |
| 2023-01-06 | Erdtmann Rainer M President and COO | Grant or award · Stock Option (Right to Buy) | +118,000 | 118,000 | ||
| 2023-01-06 | Valle Franco Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +126,300 | 126,300 | ||
| 2023-01-06 | Butler Thomas Andrew Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +354,350 | 354,350 | ||
| 2022-11-30 | Valle Franco Chief Financial Officer | Grant or award | +2,518 | $3.78 | $10K | 19,925 |
| 2022-11-14 | Hitchcock Michael J.M. Director | Purchase | +5,000 | $7.93 | $40K | 5,000 |
| 2022-11-11 | Valle Franco Chief Financial Officer | Purchase | +4,100 | $7.63 | $31K | 17,407 |
| 2022-08-16 | A2A Pharmaceuticals, Inc. 10% owner | Purchase | −30,684 | $13.87 | $426K | 4,300,000 |
| 2022-07-21 | A2A Pharmaceuticals, Inc. 10% owner | Sale | −34,658 | $11.21 | $389K | 4,330,684 |
| 2022-06-24 | A2A Pharmaceuticals, Inc. 10% owner | Sale | −34,658 | $11.76 | $408K | 4,365,342 |
| 2022-06-22 | Chen Bihua Director | Grant or award · Stock Option (right to buy) | +23,867 | 23,867 | ||
| 2022-06-22 | Ray Sumita Director | Grant or award · Stock Option (Right to Buy) | +23,867 | 23,867 | ||
| 2022-06-22 | Hitchcock Michael J.M. Director | Grant or award · Stock Option (Right to Buy) | +23,867 | 23,867 | ||
| 2022-06-22 | AGUIAR ERIC Director | Grant or award · Stock Option (Right to Buy) | +23,867 | 23,867 | ||
| 2022-06-22 | Faust Elizabeth Director | Grant or award · Stock Option (Right to Buy) | +45,755 | 45,755 | ||
| 2022-06-01 | Biomea Health, LLC 10% owner | Other disposition | −4,365,342 | 0 | ||
| 2022-05-31 | Valle Franco Chief Financial Officer | Grant or award | +3,307 | $4.67 | $15K | 13,307 |
| 2022-03-03 | Ray Sumita Director | Grant or award · Stock Option (Right to Buy) | +21,461 | 21,461 |
Page 4 of 6 · 106 trades